Trauma Oxygen Levels: New Standards Explained
- Trauma patients arriving at hospitals may not need as much supplemental oxygen as commonly thought.
- Adit Ginde, professor of emergency medicine and lead investigator of the SAVE-O2 study, said the traditional approach has been to flood the body with oxygen, assuming severe trauma...
- The problem with excessive oxygen, Ginde explained, is that hemoglobin can only carry so much.
New research flips the script on oxygen therapy for trauma patients. Discover how a recent study suggests that lower oxygen targets, achieving normoxemia (90-96% saturation), could lead to improved outcomes. This groundbreaking finding challenges the customary practice of over-oxygenation,potentially benefiting military and civilian populations alike. The study, involving nearly 13,000 patients, shows that reducing supplemental oxygen may increase oxygen-free days and shorten hospital stays. This research, funded by the U.S.Department of Defense, may soon reshape trauma care guidelines. Learn how this impacts frontline care and resource-limited settings. News Directory 3 highlights the implications for revised national guidelines. Discover what’s next for patients.
Lower Oxygen Targets May Benefit Trauma Patients, Study Finds
Updated June 28, 2025
Trauma patients arriving at hospitals may not need as much supplemental oxygen as commonly thought. A new study published in JAMA Network Open indicates that targeting lower oxygen saturation levels could lead to improved outcomes. Researchers at the University of Colorado School of Medicine led the study.
Dr. Adit Ginde, professor of emergency medicine and lead investigator of the SAVE-O2 study, said the traditional approach has been to flood the body with oxygen, assuming severe trauma creates a deficit. The study,however,revealed that aiming for oxygen saturation between 90-96% – a state known as normoxemia – yielded similar,and sometiems superior,results.
The problem with excessive oxygen, Ginde explained, is that hemoglobin can only carry so much. Oversaturation delivers unneeded oxygen to the lungs, possibly causing harm, especially in trauma patients with healthy lungs.
The research, funded by the U.S. Department of Defense,involved nearly 13,000 patients at eight level 1 trauma centers. The goal was to determine if targeting normoxemia could safely increase the number of days patients could breathe without supplemental oxygen. Patients received only enough oxygen to maintain saturation within the 90-96% range.
The findings showed that researchers could safely reduce supplemental oxygen without increasing mortality or time spent in hypoxemia, a dangerous oxygen deficiency. Ginde noted the strong evidence that patients fared at least as well within the normoxemia range.
“We saw strong evidence that patients did at least as well by being in this normoxemia range. That was good,” Ginde said. “We wanted to then see their clinical outcome, which we measured with supplemental oxygen-free days, a combination of survival and the time spent receiving supplemental oxygen. we saw a signal for advancement, especially when patients were not on the ventilator. Patients had more days alive and free of supplemental oxygen and spent less time in the hospital, which is a positive sign.”
The SAVE-O2 project initially focused on military applications, aiming to reduce oxygen dependence during combat evacuation.Ginde said the goal was to determine if the military could safely provide frontline care with less oxygen.The research has already influenced 10 Joint Trauma system guidelines,and Ginde’s team received an award at the Military Health System Research Symposium in 2023.
The CU Center for COMBAT Research emphasizes the dual applicability of its work. Ginde stated that determining adequate oxygen levels and reducing supplemental oxygen benefits both military and civilian populations,especially in resource-limited settings. This research highlights the importance of normoxemia in trauma recovery.
What’s next
Ginde hopes the findings will lead to revised guidelines for trauma patients nationwide.His team is now testing an autonomous oxygen titration device, O2Matic, which uses a closed-loop system to deliver precise oxygen levels. The device, already approved in Europe, is undergoing FDA evaluation in the U.S.